One of the most frequently asked questions we get from our survey participants and clients is about how to compensate non-investor/independent board members. Non-investor board members contribute to private company boards because they typically have...
In September 2022, Fortune used Thelander data to look at CEO compensation by financing and valuation. With the challenging fundraising environment, private companies staying private longer and shifting valuations, we wanted to see how the data has changed. Chart...
In March 2023, we looked at the gender pay gap for life science CEOs. Almost a year later, we are sharing new data from the J.Thelander Platform, which looks at the number of female CEOs in life sciences...
Welcome back to the first Private Company Digest of 2024. Following a successful week at the J.P.Morgan Healthcare Conference, we hosted a women's event at Tiffany & Co honoring more than 300 women executives and...
In this month's Thelander Digest, we are excited to give you a peak at some of our findings from the Thelander 2023 Year-End Merit Increase, Option Pool & Bonus Survey. With more than 350 participating companies,...
Welcome back to the Thelander Private Company Digest. We have a special November edition with a guest writer, Jonathan Norris, who is a Managing Director at HSBC Innovation Banking. In our newsletter, he clearly explains everything...
Private Company edition of our Monthly Newsletter: "The Thelander Digest"
Lately, women in the workforce have been regularly making headlines. We've seen topics such as the "number of women in the workforce tops pre-pandemic levels for the first time" and that "more mothers are working...
A few years ago, we added new questions to the Thelander-PitchBook Investment Firm Compensation Survey to collect data on carry dollars at work. Using this data, we'll be looking at insights on carry dollars at work and how...
For our August newsletter, we look at data from biotech companies to see how stage of development impacts compensation for its CEOs.The different stages of development can be categorized into five groups:1) Pre-Clinical 2) First in Man 3) FDA Clinical...
